NEW YORK (Reuters Health) – A Canadian study confirms an increased risk of uveitis and scleritis in
first-time users of oral bisphosphonates.
Author: ModernMedecine
Investigational DME agent nears phase II trial
iCo Therapeutics and JDRF, formerly the Juvenile Diabetes Research Foundation, have joined forces in a
phase II clinical trial to investigate the investigational drug iCo-007 as a treatment for diabetic macular edema
(DME).
Systemic, localized treatment both effective for uveitis
Both systemic and localized treatment for vision-threatening uveitis are effective in improving visual
acuity and controlling uveitis and macular edema, according to results from the Multicenter Uveitis Steroid
Treatment (MUST) trial as present…
Former ARVO executive director dies
Former Association for Research in Vision and Ophthalmology (ARVO) Executive Director Joanne G. Angle
died March 8. She was 70 and had cancer.
Common antibiotics tied to eye emergencies: study
NEW YORK (Reuters Health) – Fluoroquinolone use was linked to a higher risk of retinal detachment in a
new Canadian study.
Feds raid ‘Princeton of Pot’ in California
OAKLAND, Calif. (Reuters) – U.S. federal agents, pressing a government clampdown on medical marijuana,
raided a San Francisco Bay-area college known as the "Princeton of Pot" on Monday and briefly
detained its founder.
UK surgeons told to stop using type of hip implant
LONDON (Reuters) – Britain’s Medicines and Healthcare products Regulatory Agency has advised surgeons
to stop using a type of metal-on-metal hip implant because of the high risk of the need for revision surgery when
compared with other devices.
Ocular surface key to surgical success
The author describes a stepwise approach to assessing and addressing the ocular surface to enhance
outcomes with cataract surgery.
Dry age-related macular degeneration measurements sought
Novel strategies have been developed to track the progression of dry age-related macular degeneration
by monitoring the change in geographic atrophy and drusen using spectral-domain optical coherence
tomography.
Thermal pulsation device clears gland blockages
The FDA clearance this past February for a second-generation version of a proprietary device allows
physicians to treat both eyes simultaneously for meibomian gland dysfunction and evaporative dry eye in a
relatively painless in-office procedure.
Surgical advances hold promise
Advances in corneal and refractive surgery have helped optimize LASIK and transplantation
procedures.
Study compares drainage devices
Interim results after 2 years of follow-up in the Ahmed Versus Baerveldt Study provide prospective
evidence that aqueous drainage devices may be effective treatments for refractory glaucoma, and demonstrate the
advantages and disadvantages of e…
Lens now has better safety profile
Data from patients with the V4 model of the posterior chamber, foldable collagen copolymer phakic IOL
implanted show that it provides excellent refractive and visual results, and, thanks to design modifications, a
safety profile that is favorab…
At the podium: Be seen, be heard
In this quartery column in association with Ophthalmic Women Leaders, Beiting launches the series with
five pearls for anyone seeking more exposure from the podium.
Corneal ulcers respond to corneal collagen crosslinking therapy
Results from patients treated for refractory ulcers due to infectious keratitis show corneal collagen
crosslinking is an effective intervention that results in rapid and complete healing.
Transcleral or endoscopic cyclophotocoagulation support glaucoma therapy
Results from a retrospective review of outcomes after transcleral or endoscopic cyclophotocoagulation
for a variety of glaucoma conditions provide additional information on the efficacy and safety of these procedures,
including in select subgro…
Chicago awaits ASCRS attendees
The annual American Society of Cataract and Refractive Surgery Symposium on Cataract, IOL, and
Refractive Surgery will be held here Friday, April 20, to Tuesday, April 24.
Piecing together your retirement puzzle
When meeting with pre-retirees as well as current retirees, one of the most common areas of concern,
apprehension, and (at times) outright fear, is whether they will run out of money during retirement.
Paying the piper
The author tackles the issue of high levels of student loan debt.
Counterfeit bevacizumab found at oncology practices
Retina specialists who use compounded bevacizumab off-label to treat wet age-related macular
degeneration are being warned that counterfeit vials of the cancer drug have turned up in oncology practices in the
United States.